AI Articles and Analysis about Research and development

Explore articles and reports related to artificial intelligence for research and development, including drug development, discovery, legal research, and more.

Software Development
in the Evolving World of Medical Devices and Applications@2x

Software Development in the Evolving World of Medical Devices and Applications – with Urvashi Tyagi of ResMed

As technology advances, the lines between mobile applications and medical devices are blurring in ways that have healthcare leaders, software developers, and regulators alike facing new and unprecedented challenges.

Banner template-7-min

Artificial Intelligence at Lilly

Lilly and Company is a global pharmaceutical corporation founded in 1876 and headquartered in Indianapolis, Indiana. The company has offices in 18 countries and sells its products in approximately 125 countries worldwide. As of 2024, Lilly employs over 38,000 people globally and has an annual revenue of $34.12 billion. 

V.1 – How AI Drives Drug Development Workflows and Value Chains Across Life Sciences Enterprises-1x-min

How AI Drives Drug Development Workflows and Value Chains Across Life Sciences Enterprises – with Leaders from Benevolent and Takeda

This article/interview analysis is sponsored by BenevolentAI and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.

IT for Financial Services in the Age of GenAI-min

IT for Financial Services in the Age of GenAI – with Craig Mackereth of Rimini Street

Dozens of GPT-driven products are already on the market, and hundreds more are in development. These tools collectively aim to revolutionize traditional roles and processes, transforming them into dynamic, parallelized workflows using variants of LLM models, such as AutoGPT. Tools like GitHub Copilot, powered by OpenAI's Codex, are demonstrating significant improvements in developer productivity, with some studies showing up to a 55% increase in task completion speed. 

Driving Responsible Approaches to AI through Operations and Development Workflows

Driving Responsible Approaches to AI Through Operations and Development Workflows – with Ranjan Sinha of IBM and Tsavo Knott of Pieces

This interview analysis is sponsored by Pieces and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn more about our thought leadership and content creation services on our Emerj Media Services page.

Driving Drug Discovery Efficiencies in Life Sciences with AI-1-min

Driving Drug Discovery Efficiencies in Life Sciences with AI – with Anne Phelan of BenevolentAI

According to research from the American Society for Biochemistry and Molecular Biology, nine out of 10 drugs fail to make it to market in the clinical trials process. Researchers in the cited studies found that 40-50% of these failures are due to a lack of clinical efficacy, meaning that the drug is not able to produce its intended effect in people, and 30% were due to unmanageable toxicity or side effects.

Overcoming Cultural and Technological Hurdles for AI Integration in Life Sciences-1-min

Overcoming Cultural and Technological Hurdles for AI Integration in Life Sciences – with Daniel Ferrante of Deloitte

Far beyond surface-level 'chatbot' software, and other customer-facing support systems, the same generative AI (GenAI) capabilities having direct impacts across language workflows in front-office tasks in financial and legal services is also having a direct impact on how research teams in the life sciences space are targeting solutions for rare diseases and novel treatments. 

Header graphics – Sanofi-1-min

Artificial Intelligence at Sanofi

Sanofi is a global healthcare and pharmaceutical company. Founded in 1973, it aims to unlock and maximize the potential of critical medicines, vaccines, and self-care solutions for individuals. It accomplishes this across four global business units: Specialty Care, Vaccines, General Medicines, and Consumer Healthcare. 

Research and development

Explore articles and reports related to artificial intelligence for research and development, including drug development, discovery, legal research, and more.